Cellectis (CLLS), MD Anderson Announce Broad Preclinical and Clinical Strategic Alliance
Tweet Send to a Friend
Cellectis (NASDAQ: CLLS) and The University of Texas MD Anderson Cancer Center have entered into a research and development alliance ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE